Rogers, AR5 Active Studies

Depression Clinical Trials in Rogers, AR

Find 5 actively recruiting depression clinical trials in Rogers, AR. Connect with local research sites and explore new treatment options.

5
Active Trials
4
Sponsors
2,313
Enrolling

Recruiting Depression Studies in Rogers

RecruitingRogers, ARNCT06029439

Study to Assess the Safety and Effectiveness of NMRA-335140-501

This is a 52-week open-label extension (OLE) study that will evaluate the safety, tolerability, and effectiveness of NMRA-335140 in participants with major depressive disorder (MDD). Participants who ...

1,000 participants
Neumora Therapeutics, Inc.
View Study Details
RecruitingRogers, ARNCT06775379

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

X-NOVA2 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of azetukalner as a monotherapy in adult participants ...

450 participants
Xenon Pharmaceuticals Inc.
View Study Details
RecruitingRogers, ARNCT07172516

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

X-CEED is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of azetukalner in adult participants diagnosed with bipolar I or II disorder wh...

400 participants
Xenon Pharmaceuticals Inc.
View Study Details
RecruitingRogers, ARNCT05922878

Study of ALTO-300 in MDD

The purpose of this study is to determine efficacy differences between ALTO-300 and placebo, used adjunctively to an antidepressant, related to patient characteristics....

321 participants
Alto Neuroscience
View Study Details
RecruitingRogers, ARNCT06524830

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

This Phase 2 study (protocol number VLS-01-203) will determine the efficacy, safety, and tolerability of short-term treatment with a VLS-01 transmucosal buccal film (VLS-01-BU) in patients with treatm...

142 participants
atai Therapeutics, Inc.
View Study Details

About Depression Clinical Trials in Rogers

Depression (major depressive disorder) is a common and serious mood disorder that negatively affects how you feel, think, and handle daily activities. It affects over 280 million people globally. Treatment includes psychotherapy, antidepressant medications, and brain stimulation therapies.

There are currently 5 depression clinical trials recruiting participants in Rogers, AR. These studies are seeking a combined 2,313 participants. Research is being sponsored by Neumora Therapeutics, Inc., Xenon Pharmaceuticals Inc., Alto Neuroscience and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Depression Clinical Trials in Rogers — FAQ

Are there depression clinical trials in Rogers?

Yes, there are 5 depression clinical trials currently recruiting in Rogers, AR. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Rogers?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rogers research site will contact you about next steps.

Are clinical trials in Rogers free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rogers studies also compensate for your time and travel.

What depression treatments are being tested?

The 5 active trials in Rogers are testing new therapies including novel drugs, biologics, and treatment approaches for depression.

Data updated March 2, 2026 from ClinicalTrials.gov